Phase I/IIa study of CNM-AgZn17.

Trial Profile

Phase I/IIa study of CNM-AgZn17.

Phase of Trial: Phase I/II

Latest Information Update: 06 Feb 2018

At a glance

  • Drugs CNM AgZn17 (Primary)
  • Indications Viral infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Feb 2018 New trial record
    • 02 Feb 2018 According to the Clene Nanomedicine, this trial will commence by 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top